Lopez, 2024 - Google Patents
Connecting HIV-1 Viral Protein R Polymorphisms to Changes in Inflammatory Signals and Efficacy Testing of Essential Oils as Disinfectants Against SARS-CoV-2Lopez, 2024
View PDF- Document ID
- 2023482177935313527
- Author
- Lopez J
- Publication year
External Links
Snippet
Abstract Human Immunodeficiency Virus (HIV-1) is the causative agent for acquired immunodeficiency syndrome (AIDS). Different strains of HIV-1 have been linked to a long term non-progressor (LTNP) or rapid progressor (RP) form of disease depending on rate of …
- 101710149136 Protein Vpr 0 title abstract description 123
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Richard et al. | Small CD4 mimetics prevent HIV-1 uninfected bystander CD4+ T cell killing mediated by antibody-dependent cell-mediated cytotoxicity | |
| Guzzo et al. | Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing | |
| Casella et al. | Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing | |
| O'Brien et al. | Anti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactions | |
| Lu et al. | A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains | |
| Montefiori et al. | Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques | |
| Trifone et al. | Interaction between macrophage migration inhibitory factor and CD74 in human immunodeficiency virus type I infected primary monocyte-derived macrophages triggers the production of proinflammatory mediators and enhances infection of unactivated CD4+ T cells | |
| Hany et al. | Bryostatin-1 decreases HIV-1 infection and viral production in human primary macrophages | |
| Wilson et al. | Characterizing the relationship between neutralization sensitivity and env gene diversity during ART suppression | |
| Wang | Viral factors in non-progression | |
| Acchioni et al. | Co-infections and superinfections between HIV-1 and other human viruses at the cellular level | |
| Farr Zuend et al. | A Caulobacter crescentus microbicide protects from vaginal infection with HIV-1JR-CSF in humanized bone marrow-liver-thymus mice | |
| Lopez | Connecting HIV-1 Viral Protein R Polymorphisms to Changes in Inflammatory Signals and Efficacy Testing of Essential Oils as Disinfectants Against SARS-CoV-2 | |
| Santosuosso et al. | R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodes | |
| Holl et al. | Stimulation of HIV-1 replication in immature dendritic cells in contact with primary CD4 T or B lymphocytes | |
| Gondois-Rey et al. | Production of HIV-1 by resting memory T lymphocytes | |
| Geuenich et al. | Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures | |
| Leal | Mutations in HIV-1 Vpr Affect Pathogenesis in T-Lymphocytes and Novel Strategies to Contain the Current COVID-19 Pandemic | |
| Bricker | Investigation of Immune Interventions in SIV-Infected, ART-Treated Infant Rhesus Macaques | |
| Gomez-Rivera | HIV Infection Dynamics: From Underlying the Establishment and Maintenance to the Molecular Mechanisms of Latency | |
| Simpson | Genetic, structural, and functional exploration of the restrictive capacity of TRIM proteins against immunodeficiency viruses | |
| Mendes | Mechanisms Underlying Exosomal Trafficking of the Antiretroviral Factor Apobec3g: Implications for the Containment and Eradication of HIV-1 Infection | |
| Plitnik | Reverse Transcriptase and the Inability of SAMHD1 to Fully Restrict Macrophage Infection by HIV-1 | |
| Molyer Yildirir | SMAC Mimetics Sensitize HIV-Infected Cells to MG1-Mediated Death | |
| Scharf | Immune deterioration in HIV-1 and HIV-2 infection with a focus on CD8 T cell exhaustion |